Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Appendix A Public Meeting Agendaâ March 20, 2009 COMMITTEE ON COMPARATIVE EFFECTIVENESS RESEARCH PRIORITIZATION PUBLIC AGENDAâFRIDAY, MARCH 20, 2009 FRIDAY, MARCH 20 â PEN SESSION Stakeholderâs Presentations O â Auditorium 8:30am Welcome to Public Session (Dr. Sox) ⢠Mechanisms of announcement (email, website) ⢠Mechanisms of input (meeting and call-in presentations, web submissions) 9:00am Invited presentations from stakeholders ⢠Myrl Weinberg, National Health Council ⢠Nancy Nielsen, American Medical Association ⢠Carmella Bocchino, Americaâs Health Insurance Plans ⢠Ted Buckley, Biotechnology Industry Organization ⢠Mary Jean Schumann, American Nurses Association ⢠William Vaughan, Consumers Union ⢠Ted Epperly, American Academy of Family Physicians ⢠Randy Burkholder, Pharmaceutical Research and Manufacturers of America Question and Answer Session 167
168 INITIAL NATIONAL PRIORITIES FOR CER 10:00am ⢠Naomi Aronson, Blue Cross/Blue Shield Association ⢠Mohammad Akhter, National Medical Association ⢠Dorothy Jeffress, Center for Advancement of Health ⢠Robert Hall, American Academy of Pediatrics ⢠Teresa Lee, Advanced Medical Technology Association ⢠Antonio C. Wolff, American Society of Clinical Oncology ⢠Jack Lewin, American College of Cardiology ⢠Harold Miller, Network for Regional Healthcare Improvement Question and Answer Session 11:00am ⢠Bryan Luce, United BioSource Corporation ⢠Leah Hole-Curry, WA State Health Care Authority ⢠Erick Turner, Oregon health and Science University and Portland VA Medical ⢠Robert Harrison, California Dept of Public Health ⢠Gary Puckrein, National Minority Quality Forum ⢠Marilyn Dix Smith, International Society for Pharmacoeconomics & Outcomes Research ⢠Frederick Grover, Society of Thoracic Surgeons ⢠Douglas Hadley, CIGNA ⢠Adolph Falcon, National Alliance for Hispanic Health ⢠Roger Williams, United States Pharmacopeia Question and Answer Session 12:00pm Lunch Break 1:00pm ⢠Nada Stotland, American Psychiatric Association ⢠Ruth Lubic, Developing Families Center ⢠William Weintraub, American Heart Association ⢠Eugene Rich, Association of American Medical Colleges ⢠Merrill Goozner, Center for Science in the Public Interest ⢠Jeff Allen, Friends of Cancer Research ⢠Les Paul, National Pharmaceutical Council ⢠Steven Bailey, Society for Cardiovascular Angiography and Interventions Question and Answer Session 2:00pm ⢠Clifford Goodman, The Lewin Group ⢠Amy Abernethy, Duke University Medical Center ⢠Katie Orrico, American Association of Neurological Surgeons
APPENDIX A 169 ⢠Christopher Fox, American Association for Dental Research ⢠Amy Miller, Personalized Medicine Coalition ⢠Douglas Peddicord, Association of Clinical Research Organizations ⢠Patrick OâConnor, HealthPartners Research Foundation ⢠Janet Marchibroda, eHealth Initiative Question and Answer Session 3:00pm ⢠J mes Bray, American Psychological Association a ⢠C. Edwin Webb, American College of Clinical Pharmacy ⢠Harrison Spencer, Association of Schools of Public Health ⢠Andrew Sperling, National Alliance on Mental Illness ⢠John Brooks, University of Iowa ⢠Marty Makary, American College of Surgeons ⢠Perry D. Cohen, Parkinson Pipeline Project ⢠Morgan Downey, Health Care Consultancy ⢠Dennis Hart, Focus On Therapeutic Outcomes, Inc. ⢠Eunince K. M. Ernst, Frontier School of Midwifery & Family Nursing ⢠Carolyn Curtis ⢠Patrick OâConnor, American College of Occupational and Environmental Medicine Question and Answer Session 3:50pm Concluding remarks (Dr. Sox) 4:00pm Adjourn